JP6360795B2 - 経口製剤 - Google Patents

経口製剤 Download PDF

Info

Publication number
JP6360795B2
JP6360795B2 JP2014553002A JP2014553002A JP6360795B2 JP 6360795 B2 JP6360795 B2 JP 6360795B2 JP 2014553002 A JP2014553002 A JP 2014553002A JP 2014553002 A JP2014553002 A JP 2014553002A JP 6360795 B2 JP6360795 B2 JP 6360795B2
Authority
JP
Japan
Prior art keywords
oral preparation
weight
oral
present
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014553002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015515959A (ja
Inventor
岩本　太郎
太郎 岩本
伸幸 倉橋
伸幸 倉橋
慶一 岡
慶一 岡
知加子 武田
知加子 武田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of JP2015515959A publication Critical patent/JP2015515959A/ja
Application granted granted Critical
Publication of JP6360795B2 publication Critical patent/JP6360795B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
JP2014553002A 2012-04-30 2013-04-30 経口製剤 Active JP6360795B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261640474P 2012-04-30 2012-04-30
US61/640,474 2012-04-30
US201361783163P 2013-03-14 2013-03-14
US61/783,163 2013-03-14
PCT/JP2013/062985 WO2013165021A1 (en) 2012-04-30 2013-04-30 Oral formulation

Publications (2)

Publication Number Publication Date
JP2015515959A JP2015515959A (ja) 2015-06-04
JP6360795B2 true JP6360795B2 (ja) 2018-07-18

Family

ID=48483123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014553002A Active JP6360795B2 (ja) 2012-04-30 2013-04-30 経口製剤

Country Status (21)

Country Link
US (3) US20150126521A1 (cg-RX-API-DMAC7.html)
EP (1) EP2844232A1 (cg-RX-API-DMAC7.html)
JP (1) JP6360795B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150003898A (cg-RX-API-DMAC7.html)
CN (1) CN104271120A (cg-RX-API-DMAC7.html)
AR (1) AR091349A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013255256B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014026879A2 (cg-RX-API-DMAC7.html)
CA (1) CA2872004A1 (cg-RX-API-DMAC7.html)
CO (1) CO7151505A2 (cg-RX-API-DMAC7.html)
EA (1) EA026187B1 (cg-RX-API-DMAC7.html)
HK (1) HK1207290A1 (cg-RX-API-DMAC7.html)
IL (1) IL235111A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN09091A (cg-RX-API-DMAC7.html)
MX (1) MX2014013155A (cg-RX-API-DMAC7.html)
NZ (1) NZ630029A (cg-RX-API-DMAC7.html)
PH (1) PH12014502323A1 (cg-RX-API-DMAC7.html)
SG (2) SG11201406261QA (cg-RX-API-DMAC7.html)
TW (1) TWI594765B (cg-RX-API-DMAC7.html)
WO (1) WO2013165021A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201408114B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498556A (zh) * 2017-09-15 2019-03-22 万特制药(海南)有限公司 阿立哌唑口服溶液及其制备方法
WO2022176017A1 (ja) * 2021-02-16 2022-08-25 大塚製薬株式会社 非晶質体及び当該非晶質体を含む組成物
US11654108B1 (en) 2022-05-02 2023-05-23 Medicated Chews, Llc Sennoside medicated chews

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517886B1 (en) * 1997-06-24 2003-02-11 Biovail Corporation International Positive hydration method of preparing confectionery and the resulting product
AUPQ970300A0 (en) * 2000-08-29 2000-09-21 Massa Nominees Pty Ltd Advanced wireless network
FR2822644B1 (fr) * 2001-03-30 2005-03-11 Roquette Freres Confiserie sans sucre
JP2004099558A (ja) * 2002-09-11 2004-04-02 Medorekkusu:Kk 医薬用ゼリー組成物
JP4547994B2 (ja) * 2004-06-02 2010-09-22 救急薬品工業株式会社 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤
JP4315393B2 (ja) 2005-04-14 2009-08-19 大塚製薬株式会社 複素環化合物
WO2008050847A1 (en) * 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
AU2008237246B2 (en) * 2007-04-05 2014-06-05 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
GB0818472D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
WO2010116385A2 (en) * 2009-04-08 2010-10-14 Rubicon Research Private Limited Pharmaceutical compositions for alleviating unpleasant taste
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US20110139164A1 (en) * 2009-12-15 2011-06-16 R. J. Reynolds Tobacco Company Tobacco Product And Method For Manufacture
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
JP5611672B2 (ja) * 2010-05-28 2014-10-22 ゼリア新薬工業株式会社 経口ゼリー剤
AR082494A1 (es) * 2010-08-24 2012-12-12 Otsuka Pharma Co Ltd Composicion en torta y en suspension con contenido de derivado de carbostirilo y derivado de aceite de silicona y/o aceite de silicona
GB201016900D0 (en) * 2010-10-06 2010-11-17 Probio Asa Emulsion
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole

Also Published As

Publication number Publication date
IL235111A0 (en) 2014-12-31
IN2014DN09091A (cg-RX-API-DMAC7.html) 2015-05-22
CO7151505A2 (es) 2014-12-29
ZA201408114B (en) 2016-08-31
CA2872004A1 (en) 2013-11-07
PH12014502323A1 (en) 2015-01-12
JP2015515959A (ja) 2015-06-04
EP2844232A1 (en) 2015-03-11
AR091349A1 (es) 2015-01-28
HK1207290A1 (en) 2016-01-29
WO2013165021A1 (en) 2013-11-07
MX2014013155A (es) 2015-05-08
NZ630029A (en) 2016-05-27
SG10201608954UA (en) 2016-12-29
EA026187B1 (ru) 2017-03-31
TW201347773A (zh) 2013-12-01
SG11201406261QA (en) 2014-11-27
US20150126521A1 (en) 2015-05-07
KR20150003898A (ko) 2015-01-09
AU2013255256A2 (en) 2014-11-13
TWI594765B (zh) 2017-08-11
AU2013255256A1 (en) 2014-10-30
US20170202833A1 (en) 2017-07-20
CN104271120A (zh) 2015-01-07
EA201491995A1 (ru) 2015-02-27
US20180055840A1 (en) 2018-03-01
AU2013255256B2 (en) 2017-09-07
BR112014026879A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
JP6294479B2 (ja) 経口分散性フィルム
JP5674666B2 (ja) 崩壊性粒子組成物及び口腔内速崩壊錠
JP5941558B2 (ja) シルデナフィルを有効成分として含有し、且つ、苦味の隠蔽された高含量速溶フィルム
JP5674667B2 (ja) 崩壊性粒子組成物及び口腔内速崩壊錠
JP2015078182A (ja) 速崩壊性圧縮成型物及びその製法
US10335443B2 (en) Orodispersible film
KR20090020561A (ko) 필름 피복된 고체 투여 형태
US20210322306A1 (en) Oral dissolvable film with high load of polymeric binder
JP6360795B2 (ja) 経口製剤
US20220023198A1 (en) Oral soluble film containing sildenafil citrate
JP2019511465A (ja) Ｓｔ−２４６（テコビリマット一水和物）懸濁製剤
Dnyaneshwar et al. Oro-dispersible film dosage form: A review
JP2006028028A (ja) 経口医薬組成物
JP2006008615A (ja) 貼付用のマトリックス及びそれからなる化粧料
JP4962888B2 (ja) 経口腸溶性医薬組成物
JP7394295B2 (ja) キャンディ製剤、及び、キャンディ製剤の製造方法
JP2005179311A (ja) ゼリー状睡眠薬製剤
UA113646C2 (xx) Пероральний препарат
JP2012188383A (ja) ドネペジル塩酸塩の内用液剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170307

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170706

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170905

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171225

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180529

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180625

R150 Certificate of patent or registration of utility model

Ref document number: 6360795

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250